EU Shake-Up

Conducting clinical trials is a crucial activity for pharmaceutical companies wishing to develop new medicinal products and treatment therapies. However, the risk involved in clinical trial activities must be balanced with the medical benefit for patients, both specific and general. Thus it is important that clinical trials be regulated. Elisabethann Wright and Wim Nauwelaerts offer their comments on improving clinical trials legislation in the EU.

Download PDF Share Back To Listing
Loading data